Bacil Pharma (BOM:524516) received approval from the Bombay Stock Exchange to list 8.5 million equity shares issued on a preferential basis to non-promoters, according to a Thursday filing on the local bourse.
The shares, with a face value of 10 Indian rupees and issued at a premium of 22 rupees apiece, were cleared for listing via a BSE letter dated June 3.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.